Sridhar Prasad

Sridhar Prasad is a seasoned drug discovery R&D leader with over 20 years of experience in developing new molecular entities that have entered clinical trials and received global regulatory approval, notably for type 2 diabetes. They have held pivotal roles at major pharmaceutical companies, including Merck, Takeda, and Plex Pharmaceuticals, where they served as co-founder and Chief Scientific Officer. Sridhar has made significant contributions in structural biology and FBDD technologies, leading multiple successful drug development initiatives and securing substantial grant funding. Currently, they hold various advisory and consulting roles while also serving on the board of a stealth SPAC.